About Us

Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.

On The Road

The World’s Only Goserelin Microsphere Formulation (Baituowei) Approved in China for the New Indication of Breast Cancer


Shanghai, September 7, 2023 -- Luye Pharma Group (HKEX: 02186) and BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235) today announced that a new indication for Luye Pharma's innovative formulation, Goserelin Microspheres for Injection ...

September 07,2023

Luye Pharma Announces 2023 Half Year Results

- Remarkable payoff for innovation - - Strong revenue growth - - Accelerated commercialization worldwide - Luye Pharma Group (2186.HK) announced its 2023 half year results and recent developments on August 29, 2023. Remarkable ...

August 29,2023

Read More


Employee Stories

Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company